Clinical Trials in New York

Showing 10541-10560 of 22,668 trials

Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease

NCT03124459

This is a multicenter, phase 2 study to evaluate the safety, tolerability, pharmacodynamics (PD), efficacy, and pharmacokinetics (PK) of ACE-083 in patients with Charcot-Marie-Tooth Disease Type 1 and Type X (CMT1 and CMTX), to be conducted in two parts. Part 1 is non-randomized, open-label, dose-escalation and Part 2 is randomized, double-blind, and placebo-controlled.

Charcot-Marie-Tooth Disease

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA63 participantsStarted Jul 2017

Orange, California, United States • Aurora, Colorado, United States • Gainesville, Florida, United States +13 more locations

COMPLETEDPhase 2< 1 mile

A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

NCT03569371

The purpose of this study is to assess the safety of INCB054707 in men and women with moderate to severe hidradenitis suppurativa (HS).

Hidradenitis Suppurativa

Incyte Corporation10 participantsStarted Jul 2018

Los Angeles, California, United States • Tampa, Florida, United States • New York, New York, United States +1 more locations

Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease

A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Find Trials by Condition in New York

Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)

Natural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD

Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma

Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies.

A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.

An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma

Study of Denosumab in Subjects With Giant Cell Tumor of Bone

Implantation of the Cochlear® Nucleus® System in Adults With Single-Sided Deafness

Evaluation of PSMA Antagonist Produced by Two Different Methods

Effects of Pneumatic Vitreolysis on Vitreomacular Traction

Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing

A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration

Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))

SAR3419 in Acute Lymphoblastic Leukemia

Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)